191 related articles for article (PubMed ID: 29438631)
1. Plasma endocannabinoid levels in lean, overweight, and obese humans: relationships to intestinal permeability markers, inflammation, and incretin secretion.
Little TJ; Cvijanovic N; DiPatrizio NV; Argueta DA; Rayner CK; Feinle-Bisset C; Young RL
Am J Physiol Endocrinol Metab; 2018 Oct; 315(4):E489-E495. PubMed ID: 29438631
[TBL] [Abstract][Full Text] [Related]
2. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
[TBL] [Abstract][Full Text] [Related]
3. Effects of small intestinal glucose on glycaemia, insulinaemia and incretin hormone release are load-dependent in obese subjects.
Trahair LG; Marathe CS; Standfield S; Rayner CK; Feinle-Bisset C; Horowitz M; Jones KL
Int J Obes (Lond); 2017 Feb; 41(2):225-232. PubMed ID: 27840416
[TBL] [Abstract][Full Text] [Related]
4. Role of Endocannabinoids in Energy-Balance Regulation in Participants in the Postobese State-a PREVIEW Study.
Drummen M; Tischmann L; Gatta-Cherifi B; Cota D; Matias I; Raben A; Adam T; Westerterp-Plantenga M
J Clin Endocrinol Metab; 2020 Jul; 105(7):e2511-20. PubMed ID: 32333763
[TBL] [Abstract][Full Text] [Related]
5. Relationship between sex, APOE genotype, endocannabinoids and cognitive change in older adults with metabolic syndrome during a 3-year Mediterranean diet intervention.
Soldevila-Domenech N; Fagundo B; Cuenca-Royo A; Forcano L; Gomis-González M; Boronat A; Pastor A; Castañer O; Zomeño MD; Goday A; Dierssen M; Baghizadeh Hosseini K; Ros E; Corella D; Martínez-González MÁ; Salas-Salvadó J; Fernández-Aranda F; Fitó M; de la Torre R
Nutr J; 2024 Jun; 23(1):61. PubMed ID: 38862960
[TBL] [Abstract][Full Text] [Related]
6. Lipid stimulation of fatty acid sensors in the human duodenum: relationship with gastrointestinal hormones, BMI and diet.
Cvijanovic N; Isaacs NJ; Rayner CK; Feinle-Bisset C; Young RL; Little TJ
Int J Obes (Lond); 2017 Feb; 41(2):233-239. PubMed ID: 27811952
[TBL] [Abstract][Full Text] [Related]
7. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.
Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Wishart J; Deane AM; Rayner CK; Horowitz M; Young RL
J Clin Endocrinol Metab; 2015 Mar; 100(3):968-76. PubMed ID: 25423571
[TBL] [Abstract][Full Text] [Related]
8. The association of dietary patterns with endocannabinoids levels in overweight and obese women.
Yagin NL; Hajjarzadeh S; Aliasgharzadeh S; Aliasgari F; Mahdavi R
Lipids Health Dis; 2020 Jul; 19(1):161. PubMed ID: 32631352
[TBL] [Abstract][Full Text] [Related]
9. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
[TBL] [Abstract][Full Text] [Related]
10. Incretin secretion in humans is under the influence of cannabinoid receptors.
Chia CW; Carlson OD; Liu DD; González-Mariscal I; Santa-Cruz Calvo S; Egan JM
Am J Physiol Endocrinol Metab; 2017 Sep; 313(3):E359-E366. PubMed ID: 28655715
[TBL] [Abstract][Full Text] [Related]
11. Comparing olive oil and C4-dietary oil, a prodrug for the GPR119 agonist, 2-oleoyl glycerol, less energy intake of the latter is needed to stimulate incretin hormone secretion in overweight subjects with type 2 diabetes.
Mandøe MJ; Hansen KB; Windeløv JA; Knop FK; Rehfeld JF; Rosenkilde MM; Holst JJ; Hansen HS
Nutr Diabetes; 2018 Jan; 8(1):2. PubMed ID: 29330461
[TBL] [Abstract][Full Text] [Related]
12. Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea--specific role of oleoylethanolamide.
Jumpertz R; Wiesner T; Blüher M; Engeli S; Bátkai S; Wirtz H; Bosse-Henck A; Stumvoll M
Exp Clin Endocrinol Diabetes; 2010 Oct; 118(9):591-5. PubMed ID: 20429051
[TBL] [Abstract][Full Text] [Related]
13. Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects.
Engeli S; Lehmann AC; Kaminski J; Haas V; Janke J; Zoerner AA; Luft FC; Tsikas D; Jordan J
Obesity (Silver Spring); 2014 May; 22(5):E70-6. PubMed ID: 24616451
[TBL] [Abstract][Full Text] [Related]
14. Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide).
Hanlon EC
Psychoneuroendocrinology; 2020 Jan; 111():104471. PubMed ID: 31610409
[TBL] [Abstract][Full Text] [Related]
15. Dissociated incretin hormone response to protein versus fat ingestion in obese subjects.
Lindgren O; Carr RD; Holst JJ; Deacon CF; Ahrén B
Diabetes Obes Metab; 2011 Sep; 13(9):863-5. PubMed ID: 21554523
[TBL] [Abstract][Full Text] [Related]
16. Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer.
Grill M; Högenauer C; Blesl A; Haybaeck J; Golob-Schwarzl N; Ferreirós N; Thomas D; Gurke R; Trötzmüller M; Köfeler HC; Gallé B; Schicho R
Sci Rep; 2019 Feb; 9(1):2358. PubMed ID: 30787385
[TBL] [Abstract][Full Text] [Related]
17. Modulation of plasma N-acylethanolamine levels and physiological parameters by dietary fatty acid composition in humans.
Jones PJ; Lin L; Gillingham LG; Yang H; Omar JM
J Lipid Res; 2014 Dec; 55(12):2655-64. PubMed ID: 25262934
[TBL] [Abstract][Full Text] [Related]
18. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: a randomised controlled trial.
Pei R; DiMarco DM; Putt KK; Martin DA; Gu Q; Chitchumroonchokchai C; White HM; Scarlett CO; Bruno RS; Bolling BW
Br J Nutr; 2017 Dec; 118(12):1043-1051. PubMed ID: 29179781
[TBL] [Abstract][Full Text] [Related]
19. Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes.
van Eyk HJ; van Schinkel LD; Kantae V; Dronkers CEA; Westenberg JJM; de Roos A; Lamb HJ; Jukema JW; Harms AC; Hankemeier T; van der Stelt M; Jazet IM; Rensen PCN; Smit JWA
Nutr Diabetes; 2018 Jan; 8(1):6. PubMed ID: 29343706
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of intraduodenal whey protein hydrolysate on antropyloroduodenal motility, gut hormones, glycemia, appetite, and energy intake in lean and obese men.
Hutchison AT; Feinle-Bisset C; Fitzgerald PC; Standfield S; Horowitz M; Clifton PM; Luscombe-Marsh ND
Am J Clin Nutr; 2015 Dec; 102(6):1323-31. PubMed ID: 26561615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
